Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 27;12(12):1666.
doi: 10.3390/antibiotics12121666.

The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail

Affiliations

The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail

Mona A Abdelrahman et al. Antibiotics (Basel). .

Abstract

Over the previous three decades, the rate of caesarean sections performed worldwide has grown exponentially. In comparison to a vaginal birth, the risk of all postpartum infections is higher with a cesarean section. One of the key factors contributing to maternal morbidity is the development of infectious complications in the surgical site after a caesarean section. The primary goal of the research was to compare the efficiency of using ampicillin/sulbactam (AMS) and cefepime (CEF) to reduce the incidence of surgical site infections (SSI) following caesarean delivery. This prospective randomized study was conducted among 200 pregnant women scheduled for elective cesarean section. They were collected from the Obstetrics and Gynecology department of Beni-Suef University Hospital, and then they were randomly assigned into two groups. Group (A) received cefepime 30 min before and 12 h after cesarean delivery, while group (B) received ampicillin/sulbactam 30 min before and 12 h after cesarean delivery. The groups were matched regarding the baseline women characteristics. Comparing the cefepime to the ampicillin/sulbactam revealed that the cefepime significantly decreased superficial SSI from 27% to 14% (0.023). A significant decrease was observed in deep SSI with cefepime compared to ampicillin/sulbactam from 24% to 13% (p-value 0.045). Interestingly, when the cefepime was compared to the ampicillin/sulbactam, we noted that the incidence of endometritis significantly decreased from 13% to 5% (p = 0.048). A noted decrease in post-operative fever in cefepime as compared to ampicillin/sulbactam from 18% to 13% (p-value = 0.329). Receiving prophylactic cefepime pre- and post-cesarean delivery significantly decreases post-operative wound infection and endometritis.

Keywords: Unictam; cefepime; cesarean; surgical site infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison between the CEF and AMS regarding the post-operative infection. * p-value is significant.
Figure 2
Figure 2
Flow chart of participants’ enrollment process of study.

References

    1. Ogah C.O., Anikwe C.C., Ajah L.O., Ikeotuonye A.C., Lawani O.L., Okorochukwu B.C., Ikeoha C.C., Okoroafor F.C. Preoperative vaginal cleansing with chlorhexidine solution in preventing post-cesarean section infections in a low resource setting: A randomized controlled trial. Acta Obstet. Gynecol. Scand. 2021;100:694–703. doi: 10.1111/aogs.14060. - DOI - PubMed
    1. Azeze G.G., Bizuneh A.D. Surgical site infection and its associated factors following cesarean section in Ethiopia: A cross-sectional study. BMC Res. Notes. 2019;12:288. doi: 10.1186/s13104-019-4325-x. - DOI - PMC - PubMed
    1. Elgendy M.O., Abdelrahman M.A., Abdelrahim M.E. What should be learned from the COVID-19 pandemic for the next coronavirus pandemics? IJCMR. 2023;1:9–11. doi: 10.61466/ijcmr1010002. - DOI
    1. Gomaa K., Abdelraheim A.R., El Gelany S., Khalifa E.M., Yousef A.M., Hassan H. Incidence, risk factors and management of post cesarean section surgical site infection (SSI) in a tertiary hospital in Egypt: A five year retrospective study. BMC Pregnancy Childbirth. 2021;21:1–9. doi: 10.1186/s12884-021-04054-3. - DOI - PMC - PubMed
    1. Blum S., Cunha C.B., Cunha B.A. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship. Surg. Infect. 2019;20:439–443. doi: 10.1089/sur.2019.039. - DOI - PubMed

LinkOut - more resources